The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 study of JNJ-42756493, a pan-FGFR tyrosine kinase inhibitor, in patients (pts) with metastatic or unresectable urothelial cancer (UC) harboring FGFR gene alterations.
 
Arlene O. Siefker-Radtke
Consulting or Advisory Role - Eisai; Genentech; Janssen; Merck; NCCN; Threshold Pharmaceuticals
Speakers' Bureau - Genentech
Research Funding - Genentech; Michael and Sherry Sutton Fund for Urothelial Cancer; Millennium; NIH
Patents, Royalties, Other Intellectual Property - Methods of characterizing and treating molecular subsets of muscle-invasive bladder cancer.
 
Begona Mellado
Employment - Hospital Clinic de Barcelona
 
Karel Decaestecker
Employment - Ghent University Hospital
Research Funding - Janssen
 
John M. Burke
Employment - Rocky Mountain Cancer Centers; US Oncology
Consulting or Advisory Role - Gilead Sciences; Incyte; Janssen Biotech; Pfizer; Takeda
Travel, Accommodations, Expenses - TG Therapeutics
 
Anne O'Hagan
Employment - Janssen
Stock and Other Ownership Interests - GlaxoSmithKline; Janssen
 
Anjali Narayan Avadhani
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Bob Zhong
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Ademi E. Santiago-Walker
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Peter De Porre
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Sabine Brookman-May
Employment - Janssen; Ludwig Institute for Cancer Research
Stock and Other Ownership Interests - Janssen
 
Jesús García-Donas
Employment - Centro Integral Oncologico Clara Campal